C. Wiezalis (Dallas, United States Of America), A. Casas (Barcelona, Spain)
The predictive value of baseline spirometry values and reversibility history of the patient for a significant reversibility response in children
H. Groepenhoff, H. M. Meyer, J. E. Dankert-Roelse, A. Boonstra (Amsterdam, The Netherlands)
|  |
Bronchodilatation and natural variation in maximal in-and expiratory flow volume curves in patients with stable COPD
D. C. Richter, D. van Schalkwyk, C. M. Louw, J. R. Joubert (Cape Town, South Africa)
| |
Validation of a single concentration inhalation provocation test (SCIPT) in children
W. Hagmolen of ten Have, N. J. van den Berg, J. van der Palen, P. J. E. Bindels, W. M. C. van Aalderen (Almere, Enschede, , Amsterdam, The Netherlands)
| |
The diagnostic value of isocapnic hyperventilation of cold air in adults with suspected asthma
J. H. Cho, J. S. Ryu, H. L. Lee, S. M. Kwak (Incheon, South Korea)
| |
Effect of induced bronchospasm on peak inspiratory flow
J. Petersen, L. Rasmussen, C. Porsberg, V. Backer (Copenhagen, Denmark)
| |
Patients' perception of peakflowmeters use in Ukraine: does it pose an issue for asthma control?
A. L. Zhitinska, L. I. Romanyuk, B. B. Vengerov (Kiev, Ukraine)
| |
The influence of breathing exercises with biofeedback on the autonomic nervous activities and pulmonary function in patients with bronchial asthma (BA)
A. Smetankin, E. Gvozdev, V. Trophymov, M. Didour, V. Martchenko, E. Pavlova (Saint-Petersburg, Russia)
| |
A new valve for dry powder inhalators - evaluation of a prototype
M. Anderson, M. Svartengren (Stockholm, Sweden)
| |
In vitro performance characteristics of a novel multi-dose dry powder inhaler Airmax™ at different inspiratory flow rates
X. M. Zeng, M. Phelan, R. Crichton (London, United Kingdom; Waterford, Ireland)
| |
Assessment of the heat and humidification characteristics of newly developed novel humidifier:HME booster
S. Fukasawa, J. Ueki, T. Suzuki, F. Yoshinosuke (Tokyo, Japan)
| |
In vitro fine particle characteristics of budesonide containing MDI and DPI products
A. Väänänen, T. Mattila, P. Hanhineva, S. Häivälä, M. Karhu, E. Muttonen (Finland)
| |
Dose proportionality of in vitro fine particle dose for dry powder inhaler combination products
P. Lipniunas, J. Westfal, L. Asking (Lund, Sweden)
| |
Aerosolization of nanoparticle suspensions in ethanol using Mystic™ drug delivery technology
A. L. Cowan, D. O. Pontious, D. T. Palmer (Columbus, United States Of America)
| |
Assessment of peak inspiratory flow through dry powder inhalers in asthmatics
G. A. Pinheiro, V. C. S. Antao, J. M. Jansen (Rio de Janeiro, Brazil)
| |
Effect of device and formulation on delivery of budesonide suspensions by nebulizers
M. Keller, J. Jauernig, F. C. Lintz, M. Knoch (Munich, Germany)
| |
An in vitro comparison of nebulizer performance in normal breathing and acute airflow obstruction
A. Ari, J. L. Rau, R. Restrepo (Atlanta, United States Of America)
| |
Safety and tolerability of differing sputum induction methods in normal subjects
K. S. Yip, S. P. Tang, P. Puspanathan, K. P. Eg, P. Vijayasingham, T. Thayaparan, S. Kumar, L. C. Loh (Kuala Lumpur, Malaysia)
| |
A comparison of sputum induction methods
K. P. Eg, P. Puspanathan, S. P. Tang, K. S. Yip, P. Vijayasingham, T. Thayaparan, S. Kumar, L. C. Loh (Kuala Lumpur, Malaysia)
| |
The investigation of nitric oxide (NO) metabolites in expired air condensates (EAC) of the patients after open-heart surgery operations (OHS)
V. A. Nevzorova, K. V. Maystrovskiy, Y. V. Maystrovskaya, V. B. Shumatov (Vladivostok, Russia)
| |